Figure 3. Analysis of TMEM100 expression in ANLTs, well differentiated hepatocellular carcinoma and poorly differentiated hepatocellular carcinoma by IHC.
A.&D. The expression of TMEM100 was strong positive in ANLTs (A:100×, D:400×). B.&E. The expression of TMEM100 was moderate positive in well differentiated hepatocellular carcinoma (B:100×, E:400×). C.&F. The expression of TMEM100 was week positive or negative in poorly differentiated hepatocellular carcinoma (C:100×, F:400×).